Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
95.347,79
-1,91%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Enochian Biosciences Inc (ENOB) Enochian Biosciences Inc (ENOB) Notizie

Enochian Biosciences Inc

ENOB
0,72
0,00 (0,00%)
20 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/7/202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202422:31EDGAR2Form 8-K - Current report
03/7/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/7/202414:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202401:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202400:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/6/202401:56EDGAR2Form SC 13D/A - General statement of acquisition of..
21/6/202422:03EDGAR2Form 8-K - Current report
30/4/202422:49EDGAR2Form 8-K - Current report
24/4/202423:23EDGAR2Form 8-K/A - Current report: [Amend]
08/4/202423:44EDGAR2Form SC 13D/A - General statement of acquisition of..
19/3/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/3/202420:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/3/202420:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/3/202414:30EDGAR2Form 8-K - Current report
17/2/202400:11EDGAR2Form SC 13D/A - General statement of acquisition of..
16/2/202421:03EDGAR2Form SC 13D/A - General statement of acquisition of..
16/2/202415:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202414:35EDGAR2Form 8-K - Current report
16/2/202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202423:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/2/202422:33EDGAR2Form 8-K - Current report
07/2/202422:51EDGAR2Form 8-K - Current report
25/1/202423:15EDGAR2Form 8-K - Current report
24/1/202422:08EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:08EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:07EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:07EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:06EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:05EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:05EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:04EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:04EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:03EDGAR2Form SC 13D/A - General statement of acquisition of..
16/1/202423:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
16/1/202423:23EDGAR2Form 8-K - Current report
16/1/202414:06EDGAR2Form 8-K - Current report
16/1/202414:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/1/202414:00EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
Apertura: Min: Max:
Chiusura: 0,72

La tua Cronologia

NASDAQ
ENOB
Enochian Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network